SEETTAL PATEL: Open Payments
NPI 1841543725 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 11 payments from 7 companies in 2025. Trend: 2023 $116 · 2024 $249 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $170 |
| Alexion Pharmaceuticals, Inc. | 3 | $92 |
| PFIZER INC. | 2 | $45 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: RYBREVANT, ULTOMIRIS, ELREXFIO, ELZONRIS, DARZALEX, PREVYMIS, Columvi, BESPONSA.
Industry payments across FL — which companies pay providers there.
